Felbamate Drug Interactions: What to Avoid and What to Tell Your Doctor

Felbamate is a pharmacokinetically complex medication. It significantly affects the blood levels of multiple other antiepileptic drugs—and those drugs affect its own levels in return. Because most patients taking felbamate are also on one or more other anticonvulsants, understanding and managing these interactions is critical to both safety and effectiveness. This guide covers the most important drug interactions every felbamate patient and caregiver should know about.

Why Felbamate Has So Many Drug Interactions

Felbamate is a significant inhibitor of the liver enzyme CYP2C19 and is itself a substrate of CYP3A4. CYP (cytochrome P450) enzymes are responsible for metabolizing many medications. When felbamate inhibits CYP2C19, it slows the breakdown of other drugs that rely on that enzyme—causing their blood levels to rise. Conversely, drugs that induce or inhibit CYP3A4 can raise or lower felbamate's own blood levels.

This bidirectional interaction with multiple antiepileptic drugs means that when felbamate is started, dose adjustments for concurrent medications are almost always required. Your neurologist will manage this, but it's important to understand what's happening and why.

Felbamate and Phenytoin (Dilantin)

Felbamate increases steady-state phenytoin blood levels significantly. In clinical studies, adding felbamate to a stable phenytoin regimen required a phenytoin dose reduction of approximately 40% to avoid phenytoin toxicity. Signs of phenytoin toxicity include dizziness, nausea, blurred vision, and coordination problems. Your neurologist should monitor phenytoin levels closely when felbamate is started, adjusted, or stopped.

Felbamate and Valproic Acid (Depakote, Depakene)

Felbamate increases valproate blood levels by approximately 54% at full therapeutic doses. This can push valproate into toxic ranges, causing tremor, nausea, increased liver enzyme levels, and cognitive slowing. Additionally, valproic acid itself increases felbamate levels. This bidirectional interaction requires careful dose management of both drugs by an experienced neurologist. Both drugs also carry independent liver toxicity risks, so close liver monitoring is essential when they are used together.

Felbamate and Carbamazepine (Tegretol)

The felbamate-carbamazepine interaction is particularly complex. Felbamate decreases carbamazepine levels while simultaneously increasing the level of carbamazepine-10,11-epoxide (the active metabolite of carbamazepine). Higher epoxide levels can cause toxicity symptoms—dizziness, double vision, nausea—even when the parent carbamazepine level appears normal. Additionally, carbamazepine is an enzyme inducer that decreases felbamate levels by approximately 40%, requiring higher felbamate doses to achieve therapeutic effect.

Felbamate and Phenobarbital

Felbamate increases phenobarbital plasma concentrations. When felbamate is added, patients on phenobarbital may experience increased sedation, cognitive effects, and other signs of phenobarbital accumulation. Phenobarbital dose reduction may be necessary. Phenobarbital also modestly reduces felbamate levels due to its enzyme-inducing properties.

Felbamate and Hormonal Contraceptives

Felbamate may decrease the effectiveness of hormonal contraceptives, including birth control pills, patches, vaginal rings, injections, and implants. This is an important consideration for women of childbearing age. If you rely on hormonal contraception, discuss with your neurologist and OB-GYN whether a non-hormonal backup method is advisable.

Felbamate and CNS Depressants

Felbamate adds to the sedative effects of other CNS (central nervous system) depressants. This includes:

Benzodiazepines (such as clonazepam, clobazam, diazepam)

Opioid pain medications (such as oxycodone, fentanyl, morphine)

Sleep medications (such as zolpidem, eszopiclone)

Alcohol

Combined use can cause excessive sedation, respiratory depression, and impaired coordination. Always inform every healthcare provider you see—including dentists, surgeons, and urgent care providers—that you are taking felbamate.

Drugs That Affect Felbamate Levels

Because felbamate is metabolized by CYP3A4, drugs that are strong CYP3A4 inducers or inhibitors can significantly change felbamate blood levels:

Drugs that lower felbamate levels (CYP3A4 inducers): carbamazepine, phenytoin, rifampin, St. John's Wort—these increase the breakdown of felbamate, potentially reducing its effectiveness

Drugs that raise felbamate levels (CYP3A4 inhibitors): valproate, gabapentin, and some HIV antiretrovirals (e.g., atazanavir, lenacapavir)—these slow felbamate metabolism and may increase felbamate side effects

What to Tell Every Healthcare Provider

Whenever you see any healthcare provider—whether for a routine visit, urgent care, or a procedure—tell them you are taking felbamate. Include:

The drug name: felbamate (brand name Felbatol)

Your dose and frequency

All other medications you take, including OTC drugs, vitamins, and herbal supplements

For a complete guide to felbamate's side effects—including the black box warnings for aplastic anemia and liver failure—see our article Felbamate Side Effects: What to Expect and When to Call Your Doctor. And if you need help finding felbamate at a pharmacy near you, medfinder can identify which local pharmacies have it in stock.